Home / GLAND.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GLAND.NS make money? Does GLAND.NS have pricing power? What's the Earnings Whisper? Will GLAND.NS profit more as the business scales? What is GLAND.NS's management track record? Is GLAND.NS's current price justified?

Gland Pharma Limited

₹3043.4 +$1328.30 (+77.45%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹3066.3

Day Range

₹3004.3₹3096.9

Year Range

₹1573.6₹3171

Market Cap

502.19B

AVG Volume

665.88K

Trailing/Forward PE

44.42/30.84

PEG ratio

1.14

Dividend Yield

0.66%

Next Earnings Date

2026-11-06

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

GLAND.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	18B
26 Q4	17.43B
26 Q3	16.95B
26 Q2	14.87B
26 Q1	15.06B
25 Q4	14.25B
25 Q3	13.84B
25 Q2	14.06B
25 Q1	14.02B
24 Q4	15.37B

Net Income (INR) · Q

GLAND.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	3.17B
26 Q4	3.67B
26 Q3	2.61B
26 Q2	1.84B
26 Q1	2.15B
25 Q4	1.87B
25 Q3	2.05B
25 Q2	1.64B
25 Q1	1.44B
24 Q4	1.92B

Operating Income (INR) · Q

GLAND.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	3.78B
26 Q4	4.04B
26 Q3	3.27B
26 Q2	2.08B
26 Q1	2.67B
25 Q4	1.81B
25 Q3	4.8B
25 Q2	4.06B
25 Q1	3.87B
24 Q4	2.13B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Gland Pharma Limited

Video analysis: GLAND.NS

News: GLAND.NS

Similar companies